News/ News/ Oncology FDA approves Incyte’s Pemazyre for rare bile duct cancer Richard Staines bile duct cancer, cancer, cholangiocarcinoma, Incyte 0 Comment The FDA has approved Incyte’s Pemazyre (pemigatinib), the first targeted treatment for a rare cancer of the bile Share X FDA approves Incyte’s Pemazyre for rare bile duct cancer https://pharmaphorum.com/news/fda-approves-incytes-pemazyre-for-rare-bile-duct-cancer/
bile duct cancer, cancer, cholangiocarcinoma, Incyte
0 Comment
